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Background: Decision-making during pregnancy regarding different options of care can be difficult, particularly
when risks of intervention versus no intervention for mother and baby are unclear. Unbiased information and support for
decision making may be beneficial in these situations. The management of normal pregnancies at and beyond
term is an example of such a situation. In order to determine the need to develop an evidence-based decision
aid this paper searches, analyses and appraises patient decision aids and patient information leaflets regarding
care options in cases of late term and post-term pregnancies, including complementary and alternative medicine
(CAM).
Methods: A literature search was carried out in a variety of lay and medical databases. Inclusion criteria: written
information related to uncomplicated singleton pregnancies and targeted at lay people. Analysis and appraisal of
included material by means of quality criteria was set up based on the International Patient Decision Aid Standards
accounting for evidence-basing of CAM options.
Results: Inclusion of two decision aids and eleven leaflets from four decision aids and sixteen leaflets. One decision aid
met the quality criteria almost completely, the other one only insufficiently despite providing some helpful information.
Only one leaflet is of good quality, but cannot substitute a decision aid.
Conclusions: There is an urgent need for the design of an evidence-based decision aid of good quality for late-term or
post-term pregnancy, particularly in German language.
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Involvement of patients and consideration of their pref-
erences in the treatment decision has been demanded
for care options with unclear outcomes. However, the
management of pregnancy at and beyond term has been
a topic of debate worldwide within the medical and mid-
wifery community for many decades. The controversial
discussion concerns the pros and cons of induction of
labour in the light of the medicalization of the “natural”
birth, the difficulties to identify the appropriate length of
human gestation and the definition whether or not a
pregnancy is “overdue”, “post-date” or “prolonged”[1-4].
The available data have been discussed as insufficient to
demonstrate that routine induction of labour is superior
to an expectant management to reduce maternal and peri-
natal mortality and morbidity [3,5]. The meta-analysis of
Wennerholm illustrated statistical problems with rare
outcomes such as perinatal mortality. The optimal manage-
ment of pregnancies at 41 weeks and beyond is thus
unknown [6]. Therefore, the involvement of women
and their preferences in the treatment decision has
been demanded [7-9].
Perinatal mortality in developed countries is low. Never-
theless, there is an ongoing debate on whether some peri-
natal deaths, particularly stillbirths, may be avoidable
[10-12]. In the absence of solid knowledge on causes and
prevention of fetal death, one strategy that has internation-
ally been adopted is to terminate pregnancy at or beyond
term, as fetal death rates seem to rise once the estimated
date of delivery has been reached. In recent years various
medical associations have issued guidance on when and
how to recommend induction of labour (IOL)[13-15].
But a recent overview of the quality and recommenda-
tions of guidelines for the management of term and
post-term pregnancy shows, that recommendations for
induction of labour differ [16]. Internationally, there is
no consensus about when and how to routinely observe
fetal wellbeing once term is reached. This may explain
some of the uncertainties regarding different options of
care [3,4].
In 2010 the German Society of Gynecology and Obstet-
rics (Deutsche Gesellschaft für Gynäkologie und Geburt-
shilfe, DGGG) issued a consensus guideline regarding
options of care for women with uncomplicated singleton
pregnancies continuing beyond the estimated due date
(EDD) [15]. However, recommendations mainly refer to
randomized controlled trials from 1969 to the early 21st
century which have been analyzed in a meta-analysis by
Gülmezoglu et al. [11] suggesting IOL at 41 completed
weeks may significantly reduce perinatal mortality and the
risk of neonatal morbidity without increasing the caesar-
ean section rate. From these findings, the guideline con-
cludes that there are substantial reasons to generally offer
IOL after 41 completed weeks of pregnancy, and tostrongly recommend IOL after 41 + 3 weeks. The new
recommendation refers to a recently published retrospect-
ive analysis of German routine perinatal data, indicating
that the risk for fetal death in pregnancies going beyond
term is remarkably lower than found in studies published
about the situation from other countries [3]. These results
do not support the recommendation of routine induction
of labor in low risk pregnancies at 41+ 0/7 weeks of
pregnancy.
Relevant literature shows a diversity of opinions on
how and to which extent pregnant women should be in-
formed of conflicting evidence on treatment options
they will have to decide on. Recommendations regarding
patient information postulate that uncertainties need to
be addressed to patients [17]. But there is a possibility
that this imposes a dilemma on them, as there is only
the choice between risks that cannot be quantified [18].
Decision aids are defined as tools to help people partici-
pating in their health decisions in ways they prefer. They
aim to provide facts about a person’s condition, the
options and their features, help people to clarify their
values and help them to share their values with their
health care practitioner and others, in order for a course
of action to be planned that matches their values. Pa-
tient decision aids do not advise people to choose one
option over another. They do not replace counseling
from a health care practitioner. Instead, they prepare
people to discuss the options with their health care prac-
titioner [19].
Informational and decision support needs of pregnant
women
There is some evidence that women during pregnancy are
not always informed or included in decision-making.
Thompson conducted a survey in Queensland, Australia,
about the perceived information about risks and benefits
of procedures and the role of decision making about the
procedures. 3,542 eligible women (34.2%) completed the
survey. Between 4% and 60% of women reported that they
had not been informed of the benefits and risks of the pro-
cedure they experienced. Between 2% and 34% of women
reported not having been consulted in decision-making.
Over one quarter (26%) of the women who had an episiot-
omy reported neither having been informed nor consulted
prior to the procedure. Thomson concluded that there is
an urgent need for interventions that facilitate information
provision and consumer involvement in decision-making
about several perinatal procedures, especially those per-
formed within the time-limited intrapartum care episode
[20]. Decisions concerning the management of post-term
pregnancy have been studied only in a few studies.
Dependent on the situation or the cultural context, atti-
tudes and preferences regarding the main options of post-
term women differ. The clinical management options for
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waiting, or induction of labour [12]. Watchful waiting
describes a range of regimen for monitoring fetal well-
being, including electronic fetal monitoring (CTG),
ultrasound assessment of amniotic fluid volume, and moni-
toring of fetal movements at different times past 40 com-
pleted gestational weeks. For induction of labour, there are
several methods available. Besides medical means like
cervical ripening and stimulation of contractions with
prostaglandines or oxytocin [21], labour may be provoked
by mechanical (amniotomy, membrane sweep) [22] or
complementary (raspberry leaves, castor oil, acupuncture)
methods [23-28].
Stevens developed a trial comparing two different coun-
selling styles to explore how to best include pregnant
women in the decision regarding post-term management.
She found that women were better able to realize in-
formed decision-making when they were supported by
non-directive compared to directive counselling [29].
Westfall conducted a qualitative study with childbear-
ing women about their perspectives on prolonged preg-
nancy and induction of labour. Participants of this
study initially had objections against induction of
labour; however, once they had passed the “estimated
date of delivery”, they changed their minds and used
complementary self-help measures to start labour. This
does not so much reflect concerns regarding fetal well-
being, but the inconvenience of being pregnant [30].
Roberts had the intention to invite women to consider
conservative treatment, but most women were unwill-
ing to accept the conservative management [9].
Gatward and colleagues were interested in the fears
and worries of the included women. Participants of the
natural birth group were mainly worried about the po-
tential impact of induction on the baby, whereas the in-
duction group expressed concern about the effect on
themselves and deprivation of a natural birth. Worries
in both groups were dissipated by successfully birthing
a healthy baby. But also a lack of meaningful informa-
tion was found [8]. In a trial on how information and
role in decision-making influence women’s preferences
in cases of prolonged pregnancies, Stevens et al. came
to the conclusion that the findings highlight the poten-
tial value of strategies such as patient decision aids and
health care professional education to improve the qual-
ity of information available to women and their capacity
for informed decision-making during pregnancy and birth
[29]. Heimstad conducted a trial where women in the 41st
gestational week were randomized to a waiting group or
an induction group and asked about their attitudes to-
wards post-term pregnancy [7]. No relevant differences in
the outcomes related to morbidity of infants or mothers
could be found. In the induction group, only 74% of
women said they would prefer the same managementin future pregnancies; also 38% of women who had ser-
ial antenatal monitoring would prefer this option again.
Therefore it was stated, that in case of uncomplicated
pregnancy and continued surveillance, women’s own
wishes may guide the decision to induce or monitor a
pregnancy beyond 41 weeks. However, for this decision
the adequate information materials have to be available.
Patient decision aids, as special types of patient infor-
mation, are particularly appropriate to facilitate pa-
tients’ involvement in decision- making and to help
patients to deliberate the advantages and disadvantages
of different options of care [31]. Accordingly, we judge
a patient decision aid to be a possible tool, supporting
pregnant women and health care professionals for the
involvement of pregnant women in the obstetric man-
agement of pregnancies continuing beyond the EDD
and for their participation in informed decision-making
with regard to the various options of care.
Information about and the use of complementary and
alternative medicine (CAM)
During pregnancy, depending on the definition of CAM,
between 1% and 87% of pregnant women use complemen-
tary and alternative medicine according to a very recent lit-
erature review by Hall et al. [32]. In United States, a survey
among pregnant women with a response rate of 74.3%
showed, that in 2013 68.5% of participants reported CAM
use during their pregnancies. The authors concluded, that
by this given frequency of CAM use obstetrical providers
should be informed about CAM and incorporate discus-
sions about its use into routine patient assessments [33].
Complementary and alternative medicine are also increas-
ingly popular amongst midwives in different countries [34].
Also the inquiry of Steel in Australia among 1 800 pregnant
women emphasized the necessity for a collaborative ap-
proach of interactions between pregnant women, conven-
tional maternity health providers and CAM practitioners to
accommodate appropriate information transferal and coor-
dinated maternity care [35].
Reasons why people use complementary medicine have
been studied widely. One main reason is the wish to find
methods and ways to become active as a patient, and be
able to influence one’s own health [36]. This intention
should be taken into account when regarding the incon-
clusive evidence concerning CAM methods to support in-
duction of labour. Only a small number of studies have
been conducted worldwide, and few systematic reviews
have been published. Kavanagh et al. only found one small
study on the effect of sexual intercourse on labour for
their 2008 Cochrane review [23]. The result is inconclu-
sive; the small study was underpowered. As far as breast
stimulation for the same purpose is concerned, the same
research team found six trials for inclusion in their 2009
Cochrane review. Breast stimulation appears beneficial
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72 hours and seems to have a protective effect on postpar-
tum hemorrhage [25]. Smith et al. updated a Cochrane re-
view on homeopathy for inducing labour. They found that
the demand for homeopathy among pregnant women is
high, but the body of evidence is poor [27]. Hall examined
the evidence on multiple methods to induce labour and
stated that in spite of women demanding CAM there is a
lack of research. However, acupuncture, raspberry leaf tea
and breast stimulation appear beneficial [28]. For castor oil,
three studies were included in a 2013 Cochrane review. All
were of poor methodological quality and did not produce
any significant results [24]. Another 2013 Cochrane review
on acupuncture for IOL reported inconsistent results of the
14 RCTs that they included [26]. All authors agreed on the
urgent need for more well designed studies on the topic, as
pregnant women have a particular interest in CAM.
In 2014 Steel et al. conducted a nationwide survey among
women and their CAM use. The participants’ responses
were analyzed to examine the relationship between the use
of CAM and adverse birth outcomes from their most re-
cent pregnancy. Of the respondents (n = 1835; 79.2%), there
were variations in birth outcomes for the women who used
different forms of CAM. Notably, the outcome which was
most commonly associated with CAM use was emotional
distress. This was found to occur more commonly in
women who practiced meditation/yoga at home, used
flower essences, or consulted with a chiropractor. In con-
trast, women who consulted with a chiropractor or con-
sumed herbal teas were less likely to report a premature
birth, whilst participation in yoga classes was associated
with an increased incidence of post-partum/intra partum
haemorrhage [35]. Even when women use complementary
medicine they want to receive evidence-based patient infor-
mation about risks and missing evidence in the case of
CAM options [37]. Until now, CAM options have rarely
been included into the information and counseling tools
like evidence-based decision aids.
We conclude that information on CAM for induction of
labour needs to be part of a person- centred, evidence-
based decision aid. Therefore, this article identifies, analyzes
and appraises existing decision aids regarding the obstetric
management of pregnancies continuing beyond the esti-
mated day of delivery (EDD), including CAM-options, in




We took an inventory of existing decision aids for the ob-
stetric management of late term (40 + 1 to 41 + 6 weeks of
gestation) and post term (≥42 + 0 weeks of gestation)
pregnancies. Inclusion criteria: a) decision aids or other
printed information material for pregnant women, b)published in German or English language, c) available on
the Internet.
Exclusion criteria: a) Information for other groups, for
example midwives, b) in languages other than German
or English, c) informally designed patient information or
decision aids. The identified decision aids were analyzed
and appraised by means of quality criteria, which we set
up on the basis of the “IPDAS patient decision aid user
checklist” [38].
Since it is known that decision aids do not always use
evidence-based material [18], we decided also to include
other relevant types of patient information into our
examination such as information sheets, leaflets and pa-
tient handouts - which cannot be classified as decision
aids in the proper sense. Our aim was to be able to in-
clude evidence-based patient information material,
which can offer some relevant aspects for the develop-
ment of an evidence-based decision aid.
In order to compile an inventory of relevant English-
and German-language decision aids and other types of
patient information, we conducted a systematic litera-
ture search at the beginning of 2012. Results were up-
dated in early 2013. We also searched for existing
evaluations of available information, yet without any
findings.
The following databases, search engines and websites
were searched, among them deliberately also databases
predominantly targeted at lay people and thus
particularly accessible for pregnant women as well:
AAFP (American Academy of Family Physicians),
AWMF (Arbeitsgemeinschaft der Wissenschaftlichen
Medizinischen Fachgesellschaften e. V.), BZgA (Bun-
deszentrale für gesundheitliche Aufklärung), Cochrane
Library, DIMDI (Deutsches Institut für Medizinische
Dokumentation und Information), DHV (Deutscher
HebammenVerband e. V.), GOOGLE, GOOGLE scholar,
Gesundheitsinformationen des IQWIG (Institut für
Qualität und Wirtschaftlichkeit im Gesundheitswesen),
MEDLINE incl. Deutsches Ärzteblatt, MEDLINE PLUS,
MEDPILOT, MIDIRS (Midwives Information and
Resource Service), NHS (National Health Service) incl.
NICE (National Institute for Health and Clinical Excel-
lence), OHRI (Ottawa Hospital Research Institute),
PubMed (incl. MeSH- Terms), PubMed Health, UpTo-
Date, WHO/HEN.
The following search terms were used:
 English search terms and combinations:
(“post-term” OR “postterm” OR “overdue” OR
“induction of labor” OR “after due date” OR “labor,
induced” [MeSH] OR “delay of birth” OR “target date”
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“due day” OR “extended duration of pregnancy” OR
“postmaturity” OR “prolonged pregnancy” OR
“expectant management” OR “Pregnancy,
Prolonged”[MeSH] OR “term birth”[MeSH] OR
“estimated due date” OR “EDD” OR “beyond EDD”
OR “IOL”) AND (“patient handout” OR “patient hand
out” OR “patient decision aid” OR “patient aid” OR
“patient information” OR “PDA” OR “decision
guidance” OR “decision support” OR “decision-
making aid” OR “decision-making help” OR “decision-
making support” OR
“patient education handout”[MeSH] OR “decision aid”
OR “informed choice” OR
“guidance for patient”)
 German search terms and combinations:
(“Terminüberschreitung” OR “Übertragung” OR
“Einleitung der Geburt” OR
“Geburtseinleitung” OR “Geburtstermin” OR
“Errechneter Termin” OR
“Entbindungstermin”) AND (“Entscheidungshilfe” OR
“Patienteninformation” OR
“Informierte Entscheidung” OR “Patientenleitlinie”
OR “Patientenhilfe”)Inclusion criteria for assessment
We included decision aids and other types of informa-
tion for pregnant women into our assessment which
refer to uncomplicated singleton pregnancies continuing
beyond the EDD and which are addressed to medical lay
people, i.e. primarily to pregnant women themselves. Of
the various types of information for pregnant women
only those which comply with the IPDAS definition
cited above were classified as decision aids.Exclusion criteria for assessment
We excluded decision aids and other types of informa-
tion for pregnant women which refer to IOL, but which
explicitly do not cover the indications of late and post
term pregnancies. We also excluded information on IOL
whose reference to late and post term pregnancies is
confined to merely listing those terms as possible indica-
tions for IOL without giving any further information.
The search, the application of the inclusion and exclu-
sion criteria and the classification of patient information
as decision aids or other types of patient informationwere carried out independently by two authors (CS, BB).
Discrepancies were resolved by discussion.
Critical appraisal
For the analysis of the identified decision aids and other
types of patient information, we designed a checklist. To
this end the design of our checklist was based on the cri-
teria relating to content and development process set
out in the “IPDAS patient decision aid user checklist”
[38]. The checklist has been developed in cooperation
with gynecologists and midwiferies.
We included all of the I. Section (Content Criteria) with-
out the criteria related to tests. We then tailored the check-
list for the specific demands of the decisional situation of
pregnant women at and beyond term (No.1.2.1-1.2.3;1.2.5,
see Additional file 1). We added two further questions
(No. 4.4; No. 4.5) to ask for further references and further
support services, because of the evidence for further com-
municative support needs [37]. In consideration of the
interest among many pregnant women in complementary
and alternative approaches, the supply of evidence-based
information on the effectiveness or ineffectiveness of care
options from the field of complementary and alternative
medicine (CAM) was included as a further quality criterion
(No.1.6, see Additional file 1). We looked at those treat-
ment options that are commonly used in maternity care
context and evaluated those in relation to existing or miss-
ing evidence [17]. The following criteria have been added:
Does it refer to natural and complementary or alternative
(CAM) methods of labour stimulation? (No. 1.6.1. mem-
brane sweep/No 1.6.2. sexual intercourse/ No 1.6.3. nipple
stimulation, No 1.6.4. CAM methods (e. g. castor oil, rasp-
berry leaf tea, acupuncture)).
We added question No. 1.9 about references to rele-
vant guideline recommendations to relate the decision
aid to the health care system of the users, because pa-
tients might be afraid of discussing evidence with their
health care providers and should be informed about
medical guidelines as well.
In the section II. (Developmental process) we added
question No. 2.1 about naming the developer and deleted
the question about reporting steps to find, appraise,
summarize evidence, because further educational interven-
tion would have been necessary to develop this abilities in
lay persons [19]. The language level was judged according
to the sub-criteria listed under “Does the decision aid use
plain language?” on p. 8 of Additional file 1. The checklist
was discussed with several obstetricians and with specialists
in evidence-based patient information. Section III (Effect-
iveness) we could not apply, because we could not identify
any evaluation studies related to the identified decision aids.
Our checklist contains 49 criteria, of which 30 refer to
content and 19 on the development process of the
decision-aids and information. Some of the criteria
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file 1). The checklist was then used to analyze and ap-
praise the decision-aids as well as the information for
pregnant women. The information leaflets for pregnant
women describe the situation and options of care (IOL
versus watchful waiting) for pregnant women at and
beyond term, but do not particularly facilitate a deci-
sional process. This is why some of our appraisal cri-
teria may not strictly be applicable. Nonetheless, we
decided to also apply the checklist to types of informa-
tion other than decision aids in order to assess to
which extent those would also be capable of facilitating
pregnant women’s decision-making process. The authors
(CS, BB) independently analyzed and appraised the de-
cision aids and other kinds of information for pregnant
women. Discrepancies were resolved by discussion.
Ethical approval
No experimental research has been done and no patients
have been involved. Only patient information material was
analyzed. Therefore no ethical approval was obtained and
no informed consent procedure was realized.
Results
Main findings
We identified four decision aids and sixteen information
leaflets for pregnant women. One of the decision aids [39]
was excluded as it was targeted at health care profes-
sionals, not lay people. Another decision aid [40] was ex-
cluded, as it dealt with IOL, but did not explicitly cover
the indications of late and post term pregnancies. Three
information leaflets [41-43] were excluded, because their
references to late and post-term pregnancies were con-
fined to merely listing prolonged pregnancy as one pos-
sible indication for IOL without providing further related
information.
The two decision aids and eleven information leaflets
included into the assessment are listed in alphabetical
order and numbered consecutively in Table 1.
The analysis of the decision aids and information leaflets
on the basis of our checklist is displayed in Additional file
1. The reference numbers of the appraised decision aids
and information leaflets quoted in brackets in the following
text are consistent with the respective numeration in Table 1
and in Additional file 1.
All of the assessed decision aids and information leaf-
lets are freely available on the respective providers’ web-
sites except for the decision aid issued by “MIDIRS” [44]
(Nr. 1) (costs: £ 11,00 in print; £ 3,60 as a downloadable
PDF version).
Decision aids
The two decision aids that we included into our assess-
ment were from Australia, issued by the University ofQueensland [45] (Nr. 2), and from the United Kingdom,
issued by MIDIRS (Midwives Information and Resource
Service) [44] (Nr. 1), an organization providing information
resource to support the professional development of
midwives. Both decision aids provide detailed informa-
tion about the various options of care in cases of late
and post term pregnancies. None of them gives an
exact definition of a late term pregnancy, i.e. a preg-
nancy continuing beyond the EDD as opposed to a post
term, post-date or prolonged pregnancy, i.e. a preg-
nancy continuing beyond 42 completed weeks. This
may be owed to the fact that in Anglo-Saxon countries
obstetricians – without any further implications - tend
to define “term” as a period of time rather than on one
particular date, as is usual in Germany.
While both decision aids explain the difficulties of the
exact determination of gestational age, and describe the
risks associated with late and post term pregnancies,
only the British one discloses the uncertainties around
the calculation of these risks.
Among the methods of stimulating labor before 42
completed weeks, the Australian decision aid only dis-
plays the membrane sweep, whereas the British one add-
itionally describes natural (sexual intercourse, nipple
stimulation) and alternative (castor oil, raspberry leaf
tea, acupuncture) ways of labor stimulation.
In both publications the two basic options of “watchful
waiting” and IOL are presented and the respective pro-
ceedings under each of these options are described.
However, the description of the different ways of IOL in
the British decision aid is comparatively short. In con-
trast to the Australian decision aid, the British one does
not display probabilities for possible positive and nega-
tive outcomes of either option.
Whilst the British decision aid repeatedly refers to
NHS guidance, the Australian decision aid refrains from
any reference to guideline recommendations.
The display of the probabilities of clinical outcomes in
the Australian decision aid fully complies with the
IPDAS criteria. This applies in particular to the commu-
nication of risk probabilities by means of “100-person-
diagrams”, which guarantee the continuity of reference
parameters. For each risk probability reference is made
to scientific evidence, and letters from A to C rates the
quality of such evidence. In contrast, the British decision
aid fully abstains from the display of risk probabilities.
Contrary to the Australian publication, the British leaflet
only insufficiently supports pregnant women in clarify-
ing their personal values.
Whereas the Australian decision aid includes specific
tools (structured work sheet, questionnaire) to help preg-
nant women clarify their preferences and discuss them with
others, the British decision aid provides an empty sheet of
scratch paper for this purpose. The Australian publication
Table 1 Analyzed decision aids and information leaflets
Provider and source of information CC Title Year
Decision aids
1. Midwives Information and Research Service (MIDIRS) [44]
www.infochoice.org
GB When your baby is overdue for women (W12) 2008
2. The University of Queensland [45] www.qcmb.org.au/book/
menu/information_for_parents
AU Choosing how your labour will start in: The Having a Baby in
Queensland Book, Your choices during pregnancy and birth,
S. 81 - 95
2010
Leaflets
3. American Academy of Family Physicians (AAFP) [49]
www.aafp.org/afp/2005/0515/p1942.html?printable = afp
US Post-term Pregnancy: What you should know 2005




US Pregnancy: What to expect when you’re past your due date 2000, update:
2010












DE Merkblatt: Überschreitung des Geburtstermins: Wann wird




7. Institut für Qualität und Wirtschaftlichkeit im
Gesundheitswesen (IQWIG) [48] http://
www.gesundheitsinformation.de/wenn-die-geburt-des-babys-
auf-sich-warten-lasst.2686.de.html?part=geburt-wq
D Merkblatt: Wenn die Geburt des Babys auf sich warten lässt
[When birth of the baby keeps you waiting]
2008, update:
2012
8. Mayo Clinic [51] www.mayoclinic.com/health/inducing-labor/
PR00117
US Inducing labor: When to wait, when to induce 2011
9. Mayo Clinic [52] www.mayoclinic.com/health/overdue-
pregnancy/PR00116/
US Overdue pregnancy: What to do when baby’s overdue 2011
10 National Health Service (NHS Choices) [54] http://
www.nhs.uk/conditions/pregnancy-and-baby/pages/over-40-
weeks-pregnant-overdue.aspx
GB Overdue: Over 40 weeks pregnant last review:
2011
11 National Health Service (NHS Choices) [55] http://
www.nhs.uk/conditions/pregnancy-and-baby/pages/
induction-labour.aspx
GB Inducing Labor last review:
2011
12 National Institute for Health and Clinical Excellence (NICE) [56]
http://publications.nice.org.uk/ifp70
GB Induction of labour 2008
13 UpToDate [53] http://www.uptodate.com/contents/postterm-
pregnancy-beyond-the-basics?source=related_link
US Patient information: Postterm pregnancy (Beyond the Basics) 2012
(The numeration does not indicate any ranking order).
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shortness of information on pharmacological IOL as com-
pared to alternative methods and due to the fact that the
check-up methods applied under the option of “watchful
waiting” and possible disadvantages of pharmacological
IOL are the only text passages printed in bold, the British
decision aid gives the impression of a certain bias against
pharmacological IOL. Both decision aids name their au-
thors and report their qualifications, but do not disclose
whether and if so to which extent they have gone through a
systematic development process including field tests with
users.
Whereas the Australian decision aid comprises a de-
tailed bibliography of scientific evidence, the Britishpublication only refers to a corresponding publication
for health care professionals [39], which then on its part
contains a reference list.
Conflicts of interest are addressed in the Australian,
but not in the British decision aid. Both publications are
written at a generally understandable language level. The
Australian decision aid distinguishes itself by its appeal-
ing layout and by clear text-supporting illustrations. The
British leaflet is less clearly arranged and does not regard
layout aspects to the same extent.
Information leaflets
Of the eleven information leaflets included into the as-
sessment, three are from Germany (Nr. 5 [46], 6 [47],
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[52], 13 [53] and three from the UK (Nr. 10 [54], 11
[55], 12 [56]).
The German publications were issued by a govern-
ment agency, the Bundeszentrale für gesundheitliche
Aufklärung (BZgA) (Nr. 5), and by a professionally inde-
pendent scientific institute under public law, the Institut
für Qualität und Wirtschaftlichkeit im Gesundheitswesen
(IQWIG) (Nr. 6, 7). The UK publications have been devel-
oped by the National Health Service (NHS) (Nr. 10, 11)
and the National Institute of Health and Clinical Excel-
lence (NICE) (Nr. 12), which provides national guidance
and advice to improve health and social care on behalf of
the NHS [52]. Of the five US publications, two have been
issued by a physicians’ organization (Nr. 3, 4), two by a
hospital (Nr. 8, 9) and one by a private information service
for health care professionals and patients (Nr. 13).
None of the information leaflets fulfilled the IPDAS
criteria for patient decision aids, which is unsurprising,
as they are intended to provide mere information and
are not directly targeted at involving pregnant women in
the decision-making process.
Six of the eleven publications were too short and super-
ficial to be of any substantial benefit for pregnant women,
even considering the fact that they are mere information
leaflets (AAFP (Nr. 3, 4, Mayo Clinic (Nr. 8, 9); NHS
(Nr. 10, 11). Important features were missing in the 2–3
page publications. This concerned mainly graphs and tables
on risks and probabilities, as well as detailed explanations
on methods of induction. Three of the publications
provided at least some important information on late
and post term pregnancies (BZgA (Nr. 5), NICE (Nr. 12),
UpToDate (Nr. 13) with one of them also describing CAM
methods of labor stimulation (BZgA (Nr. 5). For the most
part, however, the leaflets focused one-sidedly on medical
and pharmacological IOL. As they were not immediately
aimed at shared decision-making and did not perceive and
address pregnant women in their role as decision-makers,
they were not capable of facilitating a balanced choice
for pregnant women based on their individual needs
and values.
One of the information leaflets (IQWIG: “Überschrei-
tung des Geburtstermins …” (“Beyond the due date …”)
(Nr. 6) is confined to explaining in comprehensive lan-
guage the results of a Cochrane review by Gülmezoglu
et al. [11], according to which after 42 completed weeks
of gestation the benefits of IOL outbalance the risks.
Due to its narrow subject matter this leaflet is unsuitable
for supporting pregnant women’s informed choice.
Among the mere information leaflets only the IQWIG
leaflet “Wenn die Geburt des Babys auf sich warten lässt”
(“When birth of the baby keeps you waiting”) (Nr. 7) stands
out. The question, at what point a pregnancy is to be con-
sidered “lasting too long” is discussed in detail.The German equivalents of late (“Terminüberschreitung”)
and post term or prolonged (“Übertragung”) pregnancy are
precisely defined. The methods of determining gestational
age are described at length and immanent uncertainties are
emphasized. “Watchful waiting” with its various check-up
methods is described, however, not as one of two possible
options between which pregnant women may choose, but
as the initially indicated approach for healthy pregnant
women beyond their EDD. Likewise, IOL is not so much
presented as one option among others, but rather as the
appropriate intervention to reduce perinatal mortality at
least beyond 42 completed weeks of gestation. CAM
methods of labor stimulation are discussed with reference
to the lack or insufficiency of evidence for some of them.
The pharmacological methods of IOL are described in de-
tail. A particular paragraph is dedicated to the problem of
how it may feel for a pregnant woman to be medically
induced.
Outcome probabilities are presented only selectively
and not comprehensively or systematically, which is why
the leaflet does not allow for a balanced choice based on
outcome results.
Individual values of pregnant women are not addressed.
The information sheet consists of text only, the layout is lit-
tle appealing and there are no illustrations. Tools to facili-
tate decision- making like work sheets or questionnaires
are not attached. The leaflet comprises a bibliography, to
which, however, no reference is made in the text, which
does not allow for the attribution of the evidence provided
in the bibliography to specific text passages. Only one text
passage refers to a hyperlink providing the results of a
study.
In particular with regard to its itemization, the leaflet
is capable of supporting pregnant women in the process
of decision-making, even though it is not designed as a
decision aid in the proper sense. Overall, it is an item of
information of good quality.
Discussion
Main findings
We were able to carry out a profound search and critical
appraisal of patient decision aids. We could not locate a
recent systematic review on evidence-based decision-aids
for pregnant women on the management of term and
post-term pregnancy. We did not find any (in German) or
a wide variation (in English) of decision-aids on the topic
that fulfilled IPDAS criteria. We were able to identify two
genuine decision aids (Nr. 1, 2) referring to late and post
term pregnancies. Our analysis showed that only the deci-
sion aid published by the University of Queensland (Nr. 2)
complies almost entirely with the criteria of our IPDAS-
based checklist. With regard to this publication only
the non-disclosure of the uncertainties around the calcula-
tion of outcome risks, the lack of a reference to respective
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tation of the development process have to be criticized.
The analysis of the decision aid issued by MIDIRS (Nr. 1)
has shown that the leaflet provides a great deal of helpful
information, but only insufficiently complies with the
IPDAS criteria, in particular with respect to the display of
outcome probabilities, reference to scientific evidence
within the publication itself, impartiality of information and
layout aspects. The analysis of the eleven information leaf-
lets for pregnant women has shown that only one leaflet
(IQWIG, Nr. 7) is capable of facilitating pregnant women’s
balanced and informed choice. As a medium of mere infor-
mation, however, the leaflet – in spite of its good quality –
cannot substitute a genuine decision aid, because decision
aids have to include several aspects such as opportun-
ities of value clarifications not included in common pa-
tient information.
Strengths
The authors based their evaluation on a evidence based
checklist, tailored to the decisional situation of pregnant
women at and beyond term. We developed our checklist
including specific informational needs of pregnant women
as an important aspect of patient centered care. To our
knowledge, no evidence-based high quality decision-aids
(DA) for healthy pregnant women exist in German lan-
guage. We consider our approach as the first DA for
healthy pregnant women in our country that will be sys-
tematically developed according to international quality
standards (IPDAS). This work will contribute to the sys-
tematic development of a decision-aid for healthy preg-
nant women on their options in term and post-term
pregnancy. This procedure – regarding existing evidence
and critical appraisal to look for best practice samples for
the developmental process of own decision aids - might be
a productive way of preparation for the development of
further decision aids.
We added insights on the availability of information
on CAM- options for induction of labour, combining the
evaluation to a relevant preference of many patients.
Our analysis showed, that CAM treatment options are
rarely included in patient information or decision aids,
even if they are commonly used in maternity care sys-
tems. Different authors regard the information about
missing evidence as an important right of patients [17].
The new ethic standards of evidence based patient infor-
mation are including the information about uncertainties
and missing evidence, especially, if treatment options are
widely used, like in the case of complementary and alter-
native medicine. So even the tools box of Patient infor-
mation of the GIN-Net works define as part of patient
information material the inclusion of information about
the uncertainties or even missing evidence concerning
treatment or screening interventions [57]. Gigerenzerand Muir Gray demand in their well known book: “We
believe that the transparency reporting of both available
as well as missing evidence is integral to a responsible
management of uncertainty, it is an integral part of any
democratic decision process, particularly when it comes
to decisions about an individual health and well being!”
[58] We share this opinion and therefore we included
the information of CAM-options even in cases with
missing evidence.
For the first time, we could combine such an evaluation
for material in German language and were able to com-
pare this to information material from other countries.
Limitations
Related to the search, we had to limit our research to
German and English languages because of feasibility, but
also to the objective of this stage of our overall project
which is to generate a general overview of existing rele-
vant decisions aids in order to determine the necessity
for an additional decision aid to be designed and tested
for German language including CAM-options. We are
aware that the evidence on many CAM options is very
limited, and appreciate the difficulty to communicate
this to clients. The construction of our checklist, which
includes other items then used in the consent and evi-
dence based checklist of IPDAS- criteria might be
worthy of discussion. The used checklist has not been
gone through a consensus process with more then four
experts in gynecology, midwifery and decision aid devel-
opment. However, we decided to include CAM-options
as relevant patient preferences. For this we added the
evidence for the needs of patients for CAM–options.
For the addition of other criteria we added relevant evi-
dence. In limiting our search to the Internet, we also
considered the fact that information made available on-
line will be capable of supporting an eminently large
number of pregnant women in the process of decision-
making. Hence it cannot be ruled out that further rele-
vant decision aids may exist, which are, for instance,
published in other languages or which are not available
on the Internet but rather only exist in print out form at
clinics or gynecologists. We could identify two good ex-
amples of decision aids in English, but not in German.
We also know that decision aids are not the only way to
solve decisional conflicts. In an evaluation of decision
aids regarding the use of hormone replacement therapy,
it was obvious that decision aids would have to be in-
cluded in counseling contexts [37]. Cheyne et al. de-
scribed the dilemma of pregnant women regarding the
decision on whether or not to have their labours in-
duced. They explained the difficulties, of weighting the
risks of minor but frequent adverse events with IOL ver-
sus the risk of rare but very harmful adverse events (still-
birth) with expectant management [59]. They showed
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and better education of health care professionals in com-
municating the individualized risks of each treatment
option. Decision aids may offer a structured procedure
to support pregnant women and health care profes-
sionals to cope with uncertainties, and they should also
include CAM options because many women ask for dif-
ferent alternatives in terms of self-activation. The actual
processes of development in the discussions of the de-
velopment of decision aids have to be considered during
the process of decision aid development. We decided to
realize an overview about already existing tools, carefully
examining them to find useful samples and study the
subject as deep as possible relating strength and limita-
tions of existing tools. This way has been chosen else-
where for the development of patient information
material [60] and we used this method to prepare the
development of a decision aid, but other ways to develop
new decision aids have been suggested [61]. A further
important step could have been put on the first place -
asking the relevant target group concerning their infor-
mational needs. Meanwhile, we also developed a ques-
tionnaire and conducted a survey about informational
needs of women. Results of this study will be published
somewhere else and can be used for the development of
a decision aid for the German target group.
For the development of a decision aid or other coun-
seling tools, the evidence of CAM options have to be
discussed and prepared in a way that pregnant women
and midwives can understand and use this information.
A further limitation is the lack of evaluation studies
concerning the effectiveness of identified decision aids.
Interpretation
Clinical practice is influenced by culturally, historically,
and politically aspects of its environment. This may even
explain some of the differences found in national guide-
lines, usual routines in clinical decision-making as well as
consumer involvement. It will have to be part of the reflec-
tion process of development and implementation to find
out whether or not such tools may be useful within the
German healthcare system. In Germany, antenatal care is
free for women with a valid health insurance. Either an
obstetrician or a midwife may provide it, but traditionally
women attend a specialist obstetrician rather than a mid-
wife for routine antenatal care, resulting in more than 90%
of pregnant women in specialist care. The objectives of
specialist-led antenatal care are risk assessment and early
detection and treatment of complications [15]. Obstetri-
cians, based on expert consensus, predominantly develop
national clinical guidance in ante partum and intra partum
care issued by the Association of Obstetricians and Gyne-
cologists. In Australia and the United Kingdom, antenatal
care is routinely provided by midwives and occasionally byGeneral Practitioners. Specialist care is sought for second-
ary care level only. The scope of midwifery practice de-
scribes the aims of antenatal care as keeping a
physiological process healthy and only then assessing
pregnant women for risks. Both countries include con-
sumer involvement in medical decision-making within
their definitions of desirable antenatal and intra partum
care. National (UK) or regional guidance (Australia) is
developed based on a systematic process including re-
view of evidence, multidisciplinary expert groups and
consumer involvement [13,61].Conclusions
As an overall finding of our study it can be emphasized
that the existing range of decision aids of good quality
regarding care options in cases of late and post term
pregnancies – at least as far as those are available on the
Internet and published in English or German language -
is insufficient. There is no relevant German-language
decision aid available.
We therefore conclude that there is an urgent need for
the development of an evidence-based decision aid of high
quality regarding the options of care in cases of uncompli-
cated singleton pregnancies continuing beyond the EDD,
particularly in German language. Also, the evidence on
complementary and alternative medicine has to be trans-
lated into an understandable, evidence-based format and
should then be incorporated into the development of deci-
sion aids. The common use of complementary therapies
without evidence-based patient information shows the
need of including CAM- options into the development of
future decision support tools.
The positive example of the decision aid issued by the
University of Queensland (Nr. 2) may serve as an im-
portant point of reference in the case of the develop-
ment of a German decision aid including information
about the existing or missing evidence concerning
CAM- options. The actual evidence concerning the de-
velopment process of decision aids should be taken into
account. Results of this search might contribute as a first
step into the framework for the design and evaluation of
complex interventions presented by Craig et al. [62],
which aims at ensuring the highest possible degree of
evidence-basing and which divides the process of devel-
opment and evaluation into several stages. The next
step, the development of the decision aid, will be divided
into a construction phase (definition of scope and pur-
pose, and selection of content, framework, and format)
and a pilot testing phase by interview, similar to other
DA –processes [63]. A multidisciplinary steering group
will supervise the process.
As we found only limited presentation of probabilities
in patient information materials and decision aids, the
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sults of the reanalysis of development criteria regarding
decision aids especially concerning the presentations of
evidence [64-66].
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